a	O
HC-11R1	O
cells	O
were	O
treated	O
with	O
5	O
ngml	O
rmIL-1β	O
for	O
the	O
indicated	O
times.Here	O
we	O
characterized	O
global	O
gene	O
expression	O
in	O
the	O
left	O
ventricular	O
myocardium	O
of	O
human	O
hearts	O
to	O
study	O
dilated	O
cardiomyopathy	O
DCM	O
,	O
a	O
common	O
cause	O
of	O
heart	O
failure	O
ultimately	O
leading	O
to	O
premature	O
death	O
14	O
.	O

In	O
addition	O
,	O
we	O
found	O
enrichment	O
for	O
the	O
GO	O
term	O
‘	O
glucose	O
metabolic	O
process	O
’	O
and	O
the	O
Kyoto	O
Encyclopedia	O
of	O
Genes	O
and	O
Genomes	O
KEGG	O
pathway	O
‘	O
glycolysisgluconeogenesis	O
’	O
.The	O
downstream	O
resource	O
and	O
health	O
consequences	O
of	O
ambiguous	O
results	O
are	O
substantial	O
and	O
can	O
include	O
clinical	O
follow-up	O
,	O
additional	O
tests	O
,	O
and	O
also	O
unnecessary	O
surveillance	O
and	O
interventions—as	O
is	O
seen	O
with	O
other	O
technologies	O
,	O
such	O
as	O
has	O
happened	O
,	O
for	O
example	O
,	O
with	O
the	O
introduction	O
of	O
prostate	O
specific	O
antigen	O
PSA	O
testing	O
9	O
.	O

420	O
and	O
the	O
ascomycete	O
Botrytis	O
aclada	O
laccase	O
were	O
much	O
higher	O
Table	O
1.An	O
expression	O
vector	O
pAEX-EGFP	O
was	O
constructed	O
in	O
which	O
the	O
5	O
’	O
-FR	O
of	O
the	O
δ-amastin	O
gene	O
was	O
fused	O
to	O
the	O
5	O
’	O
-end	O
of	O
the	O
neo	O
marker	O
gene	O
followed	O
by	O
the	O
intergenic	O
region	O
between	O
the	O
A.	O
deanei	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
I	O
and	O
II	O
genes	O
GAPDH	O
IR	O
,	O
a	O
highly	O
conserved	O
trypanosomatid	O
sequence	O
containing	O
all	O
signals	O
necessary	O
for	O
transcript	O
maturation	O
and	O
stability	O
33	O
,	O
34	O
,	O
and	O
then	O
EGFP	O
followed	O
by	O
the	O
3	O
’	O
-FR	O
of	O
the	O
δ-amastin	O
gene	O
Fig	O
.	O

Glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
GAPDH	O
was	O
used	O
as	O
a	O
loading	O
control.Glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
GAPDH	O
was	O
used	O
as	O
a	O
loading	O
control	O
.	O

dPrimer	O
set	O
for	O
FGFR2	O
is	O
in	O
a	O
region	O
of	O
FGFR2	O
that	O
is	O
present	O
in	O
both	O
FGFR2	O
IIIb	O
and	O
FGFR2	O
IIIc.The	O
expression	O
of	O
this	O
gene	O
is	O
not	O
significantly	O
influenced	O
by	O
the	O
treatments	O
and	O
it	O
is	O
similar	O
to	O
the	O
expression	O
of	O
the	O
ribosomal	O
protein	O
L29	O
gene	O
data	O
not	O
shown	O
.	O

RANK	O
variant	O
mRNA	O
relative	O
expression	O
levels	O
were	O
assessed	O
,	O
using	O
gene-specific	O
primers	O
Additional	O
file	O
1	O
and	O
the	O
One-Step	O
quantitative	O
real	O
time	O
qRT-PCR	O
kit	O
KAPPA	O
SYBR	O
FAST	O
Kappabiosystems	O
,	O
Mowbray	O
,	O
South	O
Africa	O
with	O
the	O
Rotor-Gene	O
3000	O
Corbett	O
Research	O
,	O
Sydney	O
,	O
Australia.PSA	O
-	O
prostate-specific	PROT
antigen	PROT
,	O
have	O
demonstrated	O
their	O
applicability	O
as	O
biomarkers	O
of	O
specific	O
secretory	O
functions	O
,	O
structural	O
components	O
and	O
developmental	O
alterations	O
of	O
this	O
gland	O
13-16	O
.	O

However	O
,	O
they	O
do	O
not	O
form	O
true	O
BTFs.If	O
the	O
ambiguous	O
synonym	O
PSA	O
is	O
encountered	O
in	O
text	O
,	O
and	O
the	O
word	O
Prostate	O
is	O
also	O
encountered	O
,	O
the	O
gene	O
name	O
is	O
recognized	O
.	O

To	O
quench	O
endogenous	O
peroxidase	O
,	O
the	O
sections	O
were	O
treated	O
with	O
0.3	O
%	O
vv	O
hydrogen	O
peroxide	O
,	O
and	O
then	O
blocked	O
with	O
3	O
%	O
goat	O
serum	O
for	O
30	O
min	O
,	O
followed	O
by	O
incubation	O
with	O
rabbit	O
anti	O
smooth	O
muscle	O
α-actin	O
Abcam	O
;	O
1∶500	O
or	O
rabbit	O
anti-calponin	O
1	O
Millipore	O
;	O
1∶200	O
at	O
4°C	O
overnight.Error	O
bars	O
indicate	O
95	O
%	O
confidence	O
intervals	O
and	O
sample	O
groups	O
with	O
significant	O
p	O
<	O
0.05	O
differences	O
in	O
expression	O
level	O
within	O
a	O
single	O
gene	O
are	O
indicated	O
by	O
different	O
superscripts	O
.	O

The	O
assembly	O
pathway	O
of	O
full-length	O
Dictyostelium	O
myosin	O
consists	O
of	O
a	O
nucleation	O
phase	O
followed	O
by	O
an	O
elongation	O
phase	O
Mahajan	O
and	O
Pardee	O
1996.Consistent	O
with	O
this	O
observation	O
,	O
approximately	O
10	O
%	O
of	O
3xAsp	O
myosin	O
sediments	O
at	O
50	O
mM	O
NaCl	O
,	O
demonstrating	O
that	O
regulation	O
of	O
assembly	O
is	O
not	O
an	O
all-or-none	O
process	O
.	O

To	O
facilitate	O
protein	O
localization	O
studies	O
in	O
A.	O
deanei	O
,	O
we	O
used	O
heterologous	O
expression	O
of	O
the	O
enhanced	O
green	O
fluorescent	O
protein	O
EGFP.Data	O
were	O
normalized	O
using	O
the	O
ratio	O
of	O
the	O
target	O
cDNA	O
concentration	O
to	O
that	O
of	O
the	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
gapdh	O
gene	O
.	O

An	O
additional	O
relevant	O
NINL	O
interaction	O
partner	O
identified	O
was	O
MICAL3	O
Microtubule-associated	O
Monooxygenase	O
,	O
Calponin	O
and	O
LIM	O
domain	O
containing	O
3	O
protein	O
,	O
which	O
is	O
known	O
to	O
participate	O
in	O
a	O
protein	O
complex	O
with	O
RAB6	O
and	O
RAB8	O
that	O
is	O
involved	O
in	O
the	O
fusion	O
of	O
exocytotic	O
vesicles	O
39	O
,	O
a	O
process	O
that	O
appears	O
to	O
be	O
deficient	O
in	O
the	O
retina	O
of	O
cc2d2a	O
mutants	O
and	O
ninl	O
morphants.Naringenin	O
Nar	O
inhibits	O
the	O
activation	O
of	O
PKC-ε	O
and	O
PKC-ζ	O
.	O

When	O
two	O
myosin	O
monomers	O
are	O
offset	O
by	O
14	O
nm	O
,	O
both	O
the	O
28-a.a.	O
and	O
196-a.a.	O
charge	O
repeats	O
are	O
aligned	O
to	O
maximize	O
charge	O
complementation	O
between	O
the	O
two	O
tails	O
De	O
Lozanne	O
1988.C	O
Identification	O
of	O
CIP2A	O
proximal	O
promoter	O
regions	O
that	O
were	O
affected	O
by	O
tamoxifen	O
treatment	O
.	O

The	O
amplification	O
efficiency	O
of	O
each	O
gene	O
was	O
calculated	O
using	O
a	O
dilution	O
curve	O
and	O
the	O
slope	O
calculation	O
method	O
75.For	O
semi-quantitative	O
polymerase	O
chain	O
reaction	O
PCR	O
,	O
cDNA	O
dilutions	O
were	O
prepared	O
so	O
that	O
all	O
the	O
samples	O
yielded	O
a	O
comparable	O
glyceraldehyde-3	O
phosphate	O
dehydrogenase	O
GAPDH	O
signal	O
upon	O
amplification	O
.	O

All	O
arrays	O
had	O
a	O
scale	O
factor	O
lower	O
than	O
1.4-fold	O
away	O
from	O
the	O
average	O
scale	O
factor	O
for	O
all	O
samples	O
,	O
a	O
GAPDH	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
3':5	O
'	O
ratio	O
at	O
around	O
1	O
and	O
a	O
β-actin	O
3':5	O
'	O
ratio	O
of	O
under	O
2.2.Glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
GAPDH	O
is	O
used	O
as	O
loading	O
control	O
.	O

Lectin	O
studies	O
conducted	O
in	O
the	O
human	O
prostate	O
,	O
and	O
in	O
its	O
secreted	O
glycoproteins	O
e.g.Effect	O
of	O
Jab1	O
short	O
interfering	O
RNA	O
siRNA	O
knockdown	O
on	O
p27	O
levels	O
with	O
and	O
without	O
epidermal	O
growth	O
factor	O
EGF	O
treatment	O
in	O
MDA-MB-231	O
cells	O
.	O

Functional	O
properties	O
of	O
the	O
stably	O
expressed	O
AR	O
when	O
bound	O
by	O
different	O
ligands	O
were	O
tested	O
in	O
two	O
ways	O
:	O
on	O
the	O
exogenous	O
PRE2luciferase	O
reporter	O
Fig.Anti-RNA	O
polymerase	O
II	O
antibody	O
and	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
GAPDH	O
primers	O
were	O
provided	O
by	O
the	O
manufacturer	O
as	O
a	O
positive	O
control	O
for	O
the	O
assay	O
technique	O
and	O
reagent	O
integrity	O
.	O

GAPDH	O
,	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase.The	O
striations	O
at	O
the	O
ends	O
of	O
the	O
AD-Cterm-GFP	O
3xThr	O
bipolar	O
structures	O
are	O
spaced	O
14	O
±	O
2	O
nm	O
n	O
=	O
118	O
apart	O
,	O
consistent	O
with	O
the	O
14-nm	O
spacing	O
of	O
full-length	O
Dictyostelium	O
myosin	O
.	O

More	O
recently	O
,	O
it	O
has	O
been	O
shown	O
that	O
prostate-specific	O
ablation	O
of	O
FAK	O
in	O
an	O
SV40	O
T	O
antigen	O
mouse	O
model	O
resulted	O
in	O
the	O
inability	O
of	O
prostate	O
tumours	O
to	O
progress	O
to	O
the	O
aggressive	O
neuroendocrine	O
phenotype	O
13.aFGF	O
:	O
fibroblast	O
growth	O
factor	O
gene	O
;	O
FGFR	O
:	O
fibroblast	O
growth	O
factor	O
receptor	O
gene	O
;	O
GAPDH	O
:	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
gene	O
;	O
HMBS	O
:	O
hydroxymethylbilane	O
synthase	O
gene	O
;	O
HNRPM	O
:	O
heterogeneous	O
nuclear	O
ribonucleoprotein	O
M	O
gene	O
;	O
HPRT1	O
:	O
hypoxanthine	O
phosphoribosyltransferase	O
1	O
gene	O
;	O
SRPR	O
:	O
signal	O
recognition	O
particle	O
receptor	O
gene	O
;	O
TBP	O
:	O
TATA	O
box	O
binding	O
protein	O
gene	O
;	O
F	O
:	O
forward	O
primer	O
;	O
R	O
:	O
reverse	O
primer	O
;	O
bp	O
:	O
base	O
pair	O
.	O

These	O
lists	O
contain	O
nine	O
genes	O
,	O
including	O
four	O
encoding	O
enzymes	O
of	O
the	O
glycolytic	O
pathway	O
Hexokinase	O
A	O
Hex-A	O
,	O
Phosphoglycerate	O
kinase	O
Pgk	O
,	O
Phosphoglucose	O
isomerase	O
Pgi	O
and	O
both	O
genes	O
encoding	O
Glyceraldehyde	O
3	O
phosphate	O
dehydrogenase	O
GAPDH1	O
and	O
GAPDH2	O
and	O
our	O
data	O
indicated	O
that	O
all	O
nine	O
are	O
regulated	O
by	O
Smaug	O
at	O
the	O
level	O
of	O
stability	O
andor	O
translation	O
repression	O
Additional	O
file	O
22.In	O
qRT-PCR	O
,	O
the	O
relative	O
levels	O
of	O
target	O
mRNA	O
were	O
normalized	O
to	O
those	O
of	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
.	O

In	O
experiments	O
performed	O
to	O
study	O
the	O
regulation	O
of	O
BCAR3	O
by	O
TGFβ	O
,	O
CTGF	O
was	O
used	O
as	O
a	O
positive	O
control	O
and	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
was	O
used	O
as	O
an	O
internal	O
control.Transformed	O
clones	O
were	O
pre-screened	O
for	O
laccase	O
expression	O
on	O
agar	O
plates	O
supplemented	O
with	O
ABTS	O
,	O
resulting	O
in	O
all	O
four	O
cases	O
in	O
a	O
green	O
halo	O
around	O
the	O
colonies	O
due	O
to	O
substrate	O
oxidation	O
by	O
laccase	O
.	O

Reverse	O
transcription	O
RT	O
was	O
carried	O
out	O
using	O
conventional	O
methods	O
23	O
in	O
the	O
presence	O
of	O
1	O
μg	O
RNA	O
,	O
0.63	O
pmolμL	O
random	O
hexamers	O
Canadian	O
Life	O
Technologies	O
,	O
Burlington	O
ON	O
,	O
and	O
0.025	O
UμL	O
of	O
Murine	O
Moloney	O
Leukemia	O
Virus	O
M-MLV	O
reverse	O
transcriptase	O
Canadian	O
Life	O
Technologies.The	O
cDNA	O
for	O
the	O
house	O
keeping	O
gene	O
glyceraldehyde-3-	O
phosphate	O
dehydrogenase	O
GAPDH	O
was	O
amplified	O
and	O
the	O
primer	O
sequences	O
used	O
were	O
as	O
follows	O
:	O
5'-TGGTCACCAGGGCTGCTTTT-3	O
'	O
and	O
5'-GGTGAAGACGCCAGTGGACT-3	O
'	O
.	O

The	O
expression	O
data	O
of	O
human	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
GAPDH	O
,	O
Hs99999905	O
and	O
mouse	O
beta-actin	O
Mm00607939	O
were	O
used	O
as	O
an	O
endogenous	O
control.Either	O
HC-11R1	O
cells	O
or	O
HC-11R1-RAW264.7	O
co-cultures	O
were	O
treated	O
with	O
AP20187	O
+AP	O
or	O
solvent	O
-AP	O
for	O
four	O
hours	O
and	O
analysed	O
for	O
IL-1β	O
gene	O
expression	O
.	O

Anti-RNA	O
polymerase	O
II	O
antibody	O
and	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
GAPDH	O
primers	O
were	O
provided	O
by	O
the	O
manufacturer	O
as	O
a	O
positive	O
control	O
for	O
the	O
assay	O
technique	O
and	O
reagent	O
integrity.f	O
Quantitative	O
RT-PCR	O
analysis	O
of	O
IL-1β	O
expression	O
levels	O
normalised	O
to	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
.	O

EDNRB2	O
and	O
TYRP2	O
expression	O
was	O
not	O
detected	O
in	O
*N	O
muscle	O
tissue	O
,	O
so	O
no	O
comparison	O
can	O
be	O
made	O
to	O
*FM	O
skin	O
tissue.Prostate-specific	O
antigen	O
is	O
a	O
marker	O
of	O
androgenic	O
activity	O
not	O
only	O
in	O
prostate	O
but	O
also	O
in	O
breast	O
50	O
,55	O
,56	O
.	O

Myosin	O
tails	O
have	O
a	O
striking	O
pattern	O
of	O
charged	O
a.a.	O
,	O
with	O
an	O
average	O
positive	O
charge	O
over	O
14	O
a.a.	O
followed	O
by	O
an	O
average	O
negative	O
charge	O
over	O
14	O
a.a.	O
to	O
form	O
a	O
28-a.a.	O
charge	O
repeat	O
throughout	O
the	O
tail	O
McLachlan	O
and	O
Karn	O
1983	O
;	O
McLachlan	O
1984.In	O
contrast	O
,	O
most	O
of	O
Dicer	O
and	O
Argonaute-2	O
Ago2	O
are	O
found	O
in	O
the	O
TritonX-100	O
soluble	O
fraction	O
S1	O
,	O
along	O
with	O
β-catenin	O
and	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
Gapdh	O
,	O
a	O
marker	O
for	O
proteins	O
not	O
associated	O
with	O
chromatin	O
Fig	O
.	O

qRT-PCR	O
was	O
performed	O
by	O
diluting	O
RT	O
product	O
in	O
2×	O
Universal	O
PCR	O
MasterMix	O
and	O
20×	O
TaqMan	O
Gene	O
Expression	O
Assay	O
for	O
each	O
gene	O
to	O
be	O
measured	O
:	O
chromobox	O
homolog	O
7	O
CBX7	O
Hs00980916_g1	O
,	O
docking	O
protein	O
4	O
DOK4	O
Hs00902919_g1	O
,	O
early	O
growth	O
response	O
1	O
EGR1	O
Hs00152928_m1	O
,	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
GAPDH	O
4333764F	O
,	O
mediator	O
of	O
ErbB2-driven	O
cell	O
motility	O
MEMO1	O
Hs00831646_uH	O
,	O
N-myristoyltransferase	O
2	O
NMT2	O
Hs01013924_g1	O
and	O
nuclear	O
receptor-interacting	O
protein	O
1	O
NRIP1RIP140	O
Hs00942766_s1.EGFR	O
,	O
epidermal	O
growth	O
factor	O
receptor	O
;	O
GAPDH	O
,	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
;	O
Jab1	O
,	O
c-Jun	O
activation	O
domain-binding	O
protein-1	O
;	O
pEGFR	O
,	O
phosphorylated	O
epidermal	O
growth	O
factor	O
receptor	O
.	O

*P	O
<	O
0.05	O
;	O
**P	O
<	O
0.01	O
;	O
***P	O
<	O
0.001.β-cat	O
β-catenin	O
,	O
Ago2	O
Argonaute-2	O
.	O

Glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
GAPDH	O
is	O
used	O
as	O
loading	O
control.Red	O
text	O
and	O
line	O
indicate	O
up-regulated	O
genes	O
or	O
pathways	O
in	O
domesticated	O
cottons	O
relative	O
to	O
wild	O
cottons	O
at	O
10	O
dpa	O
,	O
while	O
blue	O
text	O
and	O
lines	O
show	O
up-regulated	O
genes	O
or	O
pathways	O
in	O
wild	O
cottons	O
compared	O
to	O
domesticated	O
cottons	O
at	O
10	O
dpa	O
.	O

b	O
Immunofluorescence	O
analysis	O
confirmed	O
that	O
nuclear	O
translocation	O
of	O
Jab1	O
was	O
associated	O
with	O
downregulation	O
of	O
its	O
downstream	O
target	O
,	O
p27	O
,	O
following	O
EGF	O
treatment.Primers	O
were	O
20-21	O
nt	O
,	O
with	O
a	O
GC	O
content	O
of	O
40-60	O
%	O
,	O
either	O
overlapped	O
predicted	O
exon-exon	O
boundaries	O
by	O
3-4	O
bp	O
or	O
spanned	O
a	O
large	O
intron	O
,	O
and	O
produced	O
predicted	O
amplicons	O
of	O
55-146	O
bp	O
with	O
minimal	O
predicted	O
secondary	O
structure	O
m-fold	O
,	O
91	O
.	O

Relative	O
quantification	O
of	O
the	O
expression	O
of	O
each	O
gene	O
was	O
calculated	O
and	O
normalised	O
to	O
averaged	O
cyclophilin	O
and	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
GAPDH	O
expression	O
levels	O
as	O
indicated	O
using	O
the	O
2-ΔΔCt	O
method	O
21.Sections	O
were	O
washed	O
in	O
phosphate	O
buffered	O
saline	O
PBS	O
three	O
times	O
before	O
being	O
incubated	O
in	O
Ztyochem	O
Plus	O
HRP	O
Polymer	O
anti-rabbit	O
ZUC032	O
,	O
Source	O
Bioscience	O
,	O
UK	O
for	O
1	O
h	O
at	O
room	O
temperature	O
.	O

Because	O
PMSA	O
prostate-specific	O
membrane	O
antigen	O
is	O
overexpressed	O
on	O
most	O
prostate	O
cancer	O
cells	O
,	O
it	O
is	O
an	O
attractive	O
target	O
for	O
therapeutic	O
delivery.These	O
results	O
implied	O
that	O
the	O
fat	O
body	O
dissociation	O
is	O
done	O
by	O
a	O
certain	O
internal	O
factor	O
.	O

These	O
paracrystals	O
,	O
although	O
quite	O
rare	O
,	O
possess	O
a	O
14-nm	O
periodicity	O
similar	O
to	O
the	O
wild-type	O
tail	O
fragment.Quality	O
was	O
checked	O
using	O
the	O
TaqMan	O
Gene	O
Expression	O
Assays	O
for	O
actin	O
B	O
ACTB	O
and	O
Glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
GAPDH	O
.	O

Interestingly	O
,	O
MPA	O
is	O
reproducibly	O
a	O
strong	O
regulator	O
of	O
this	O
important	O
androgen	O
marker	O
gene.Representative	O
blots	O
and	O
densitometric	O
analyses	O
from	O
three	O
independent	O
experiments	O
are	O
shown	O
.	O

A	O
2	O
μl	O
aliquot	O
of	O
the	O
reaction	O
was	O
used	O
for	O
PCR	O
using	O
Taq	O
polymerase	O
for	O
30	O
cycles.Furthermore	O
,	O
our	O
data	O
suggest	O
that	O
mRNAs	O
encoding	O
four	O
additional	O
glycolytic	O
enzymes	O
may	O
be	O
regulated	O
by	O
Smaug	O
.	O

ADPG	O
,	O
ADP-Glucose	O
ADPG	O
;	O
BGAL	O
,	O
β-galactosidase	O
;	O
BGLU	O
,	O
β-1	O
,3-glucosidase	O
;	O
BXL	O
,	O
β-xylosidase	O
;	O
CER3WAX2	O
,	O
fatty	O
acid	O
hydroxylase	O
superfamily	O
;	O
CER4FAR3	O
,	O
fatty	O
acid	O
reductase	O
3	O
;	O
DAHP	O
,	O
3-deoxy-D-arabino-heptulosonate-7-phosphate	O
;	O
DHAP	O
,	O
dihydroxyacetone	O
phosphate	O
;	O
E4P	O
,	O
erythrose-4-phosphate	O
;	O
F6P	O
,	O
Fructose-6-Phosphate	O
;	O
GAE	O
,	O
UDP-D-glucuronate-4-epimerase	O
;	O
G1P	O
,	O
Glucose-1-Phosphate	O
;	O
G3P	O
,	O
Glyceraldehyde-3-phosphate	O
;	O
G6P	O
,	O
Glucose-6-Phosphate	O
;	O
KCR	O
,	O
beta-ketoacyl	O
reductase	O
;	O
KCS	O
,	O
3-ketoacyl-CoA	O
synthase	O
;	O
LTP	O
,	O
lipid	O
transfer	O
protein	O
;	O
PE	O
,	O
pectinesterase	O
;	O
PEP	O
,	O
phosphoenolpyruvate	O
;	O
PG2	O
,	O
polygalacturonase	O
2	O
;	O
PHS2	O
,	O
alpha-glucan	O
phosphorylase	O
2	O
;	O
PL	O
,	O
Pectate	O
lyase	O
;	O
R5P	O
,	O
Ribose-5-phosphate	O
;	O
SUS	O
,	O
sucrose	O
synthase	O
;	O
UGD	O
,	O
UDP-glucuronate	O
decarboxylase	O
;	O
UGDH	O
,	O
UDP-glucose-6-dehydrogenase	O
;	O
UGP	O
,	O
UDP-glucose	O
pyrophosphorylase	O
;	O
VLCFA	O
,	O
very	O
long	O
chain	O
fatty	O
acids	O
;	O
WBC1	O
,	O
ATP-binding	O
cassette	O
transporter	O
white-brown	O
complex	O
homolog	O
protein	O
1	O
;	O
XTH	O
,	O
Xyloglucan	O
endotransglycosylase.After	O
primary	O
antibody	O
incubation	O
,	O
the	O
sections	O
were	O
washed	O
and	O
sequentially	O
incubated	O
with	O
biotinylated	O
anti-rabbit	O
IgG	O
and	O
ABC	O
reagent	O
Vector	O
Labs	O
.	O

Cells	O
were	O
transfected	O
for	O
6	O
h	O
with	O
siRNA	O
using	O
Lipofectamine	O
2000	O
Invitrogen	O
,	O
and	O
then	O
infected	O
with	O
Ad-Epas1	O
or	O
treated	O
with	O
IL1β.This	O
enzyme	O
could	O
lead	O
to	O
glyceraldehyde	O
3-phosphate	O
production	O
via	O
the	O
second	O
part	O
of	O
the	O
EMP	O
pathway	O
involving	O
triosephosphate	O
isomerase	O
Figure	O
2	O
.	O

Based	O
on	O
these	O
results	O
,	O
it	O
was	O
decided	O
to	O
try	O
other	O
strategies	O
for	O
design	O
of	O
suitable	O
CPPs	O
to	O
deliver	O
PNAs	O
into	O
cancer	O
cell	O
lines.PCR	O
reactions	O
were	O
run	O
on	O
the	O
7500	O
real-time	O
PCR	O
instrument	O
under	O
the	O
following	O
conditions	O
:	O
hold	O
at	O
95°C	O
for	O
10	O
minutes	O
,	O
then	O
40	O
cycles	O
of	O
95°C	O
for	O
15	O
seconds	O
and	O
60°C	O
for	O
1	O
minute	O
.	O

To	O
circumvent	O
this	O
limitation	O
,	O
the	O
same	O
group	O
demonstrated	O
that	O
conditional	O
ablation	O
of	O
FAK	O
in	O
the	O
skin	O
resulted	O
in	O
an	O
absolute	O
block	O
in	O
the	O
progression	O
of	O
benign	O
papilloma	O
lesions	O
to	O
malignant	O
carcinomas	O
in	O
this	O
model	O
12.Table	O
2	O
shows	O
the	O
primer	O
sequences	O
used	O
.	O

Androgen	O
action	O
in	O
the	O
UGM	O
has	O
been	O
shown	O
to	O
be	O
necessary	O
and	O
sufficient	O
for	O
prostatic	O
development	O
for	O
review	O
1.Primer	O
sequences	O
were	O
:	O
hu	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
GAPDH	O
sense	O
,	O
AGCCACATCGCTCAGACAC	O
;	O
hu	O
GAPDH	O
antisense	O
,	O
GCCCAATACGACCAAATCC	O
;	O
hu	O
Dkk-1	O
sense	O
,	O
AGCACCTTGGATGGGTATTC	O
;	O
hu	O
DKK-1	O
antisense	O
,	O
CACACTTGACCTTCTTTCAGGAC	O
;	O
mu	O
ACTB	O
sense	O
,	O
GATCTGGCACCACACCTTCT	O
;	O
mu	O
ACTB	O
antisense	O
,	O
GGGGTGTTGAAGGTCTCAAA	O
;	O
mu	O
ALP	O
sense	O
,	O
CTGGTGGCATCTCGTTATCC	O
;	O
mu	O
ALP	O
antisense	O
,	O
CTACTTGTGTGGCGTGAAGG	O
;	O
and	O
mu	O
OPG	O
sense	O
,	O
CCTTGCCCTGACCACTCTTA	O
;	O
mu	O
OPG	O
antisense	O
,	O
CCTTGCCCTGACCACTCTTA	O
.	O

In	O
all	O
cases	O
,	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
GAPDH	O
was	O
analyzed	O
in	O
parallel	O
as	O
a	O
control	O
.	O

RNA	O
samples	O
were	O
reverse-transcribed	O
using	O
Moloney	O
murine	O
leukemia	O
virus	O
Life	O
Technologies	O
and	O
subjected	O
to	O
real-time	O
PCR	O
for	O
connective	O
tissue	O
growth	O
factor	O
CTGF	O
,	O
transmembrane	O
prostate	O
androgen	O
induced	O
RNA	O
TMEPAI	O
and	O
Smad7	O
,	O
with	O
ribosomal	O
18S	O
RNA	O
used	O
as	O
an	O
internal	O
control.After	O
endogenous	O
peroxidase	O
blocking	O
3	O
%	O
wv	O
H2O2	O
,	O
sections	O
were	O
pre-incubated	O
in	O
blocking	O
solution	O
10	O
%	O
goat	O
serum	O
for	O
1	O
h	O
at	O
room	O
temperature	O
and	O
incubated	O
overnight	O
at	O
4	O
°C	O
at	O
1100	O
dilution	O
with	O
calponin	O
antibody	O
ab46794	O
,	O
Abcam	O
,	O
UK	O
.	O

RNA	O
500	O
ng	O
was	O
reverse	O
transcribed	O
using	O
Superscript	O
II	O
Life	O
Technologies	O
,	O
Darmstadt	O
,	O
Germany	O
and	O
used	O
for	O
SYBR	O
green-based	O
real-time	O
polymerase	O
chain	O
reaction	O
PCR	O
using	O
a	O
standard	O
protocol	O
Applied	O
Biosystems.DAPI	O
,	O
4'-6-diamidino-2-phenylindole	O
;	O
EGFR	O
,	O
epidermal	O
growth	O
factor	O
receptor	O
;	O
GAPDH	O
,	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
;	O
Jab1	O
,	O
c-Jun	O
activation	O
domain-binding	O
protein-1	O
;	O
pEGFR	O
,	O
phosphorylated	O
epidermal	O
growth	O
factor	O
receptor	O
.	O

GAPDH	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
,	O
PKC	O
protein	O
kinase	O
C	O
,	O
TGF	O
transforming	O
growth	O
factor	O
,	O
PMA	O
phorbol	O
12-myristate	O
13-acetateRepresentative	O
blots	O
are	O
shown	O
.	O

In	O
the	O
nucleation	O
phase	O
,	O
a	O
parallel	O
dimer	O
forms	O
in	O
which	O
two	O
myosin	O
monomers	O
self-associate	O
in	O
a	O
parallel	O
orientation	O
with	O
a	O
14-nm	O
stagger.However	O
,	O
the	O
AR	O
were	O
not	O
functional	O
,	O
based	O
on	O
transcription	O
assays	O
with	O
MPA	O
or	O
DHT	O
,	O
and	O
by	O
RT-PCR	O
transcript	O
expression	O
of	O
the	O
androgen-responsive	O
prostate-specific	PROT
antigen	PROT
PSA	O
gene	O
not	O
shown	O
.	O

Across	O
breed	O
and	O
tissue	O
gene	O
expression	O
analysis	O
by	O
SYBR	O
Green	O
qPCR	O
of	O
*FM	O
Silkie	O
breed	O
tissue	O
and	O
*N	O
New	O
Hampshire	O
breed	O
calibrated	O
to	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
GAPDH.Epidermal	O
growth	O
factor	O
EGF	O
influences	O
activity	O
of	O
Jab1	O
downstream	O
genes	O
.	O

Blue	O
and	O
pink	O
shaded	O
boxes	O
show	O
enriched	O
pathways	O
in	O
wild	O
and	O
domesticated	O
cottons	O
compared	O
to	O
their	O
counterparts	O
,	O
respectively.For	O
instance	O
,	O
in	O
the	O
term	O
Prostate	O
Specific	O
Antigen	O
the	O
word	O
Prostate	O
appears	O
less	O
than	O
1	O
,000	O
times	O
in	O
the	O
dictionary	O
.	O

Prostate-specific	PROT
antigen	PROT
is	O
a	O
marker	O
of	O
androgenic	O
activity	O
not	O
only	O
in	O
prostate	O
but	O
also	O
in	O
breast	O
50	O
,55	O
,56.6a	O
and	O
by	O
regulation	O
of	O
the	O
endogenous	O
prostate-specific	PROT
antigen	PROT
transcript	O
Fig	O
.	O

Quantitative	O
RT-PCR	O
was	O
used	O
to	O
analyse	O
IL-1β	O
mRNA	O
expression	O
normalised	O
to	O
levels	O
of	O
cyclophilin	O
and	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
GAPDH.Interestingly	O
,	O
MPA	O
is	O
reproducibly	O
a	O
strong	O
regulator	O
of	O
this	O
important	O
androgen	O
marker	O
gene	O
.	O

5b.We	O
next	O
addressed	O
the	O
contribution	O
of	O
each	O
PR	O
isoform	O
individually	O
in	O
HeLa	O
cervical	O
and	O
T47D-Y	O
breast	O
cancer	O
cells	O
exogenously	O
expressing	O
PR-A	O
or	O
PR-B	O
,	O
cotransfected	O
with	O
PRE2luciferase	O
,	O
and	O
treated	O
with	O
increasing	O
concentrations	O
of	O
R5020	O
,	O
MPA	O
,	O
or	O
DHT	O
Fig	O
2b–e	O
.	O

Quality	O
was	O
checked	O
using	O
the	O
TaqMan	O
Gene	O
Expression	O
Assays	O
for	O
actin	O
B	O
ACTB	O
and	O
Glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
GAPDH.Using	O
RT-PCR	O
,	O
we	O
assessed	O
the	O
ability	O
of	O
AR	O
in	O
Y-AR	O
cells	O
to	O
regulate	O
endogenous	O
expression	O
of	O
this	O
gene	O
Fig	O
.	O

a	O
The	O
pAEX	O
series	O
of	O
plasmids.Furthermore	O
,	O
embryonic	O
UGM	O
has	O
the	O
ability	O
to	O
re-differentiate	O
prostate	O
cancer	O
cells	O
and	O
to	O
reduce	O
tumor	O
growth	O
46	O
.	O

These	O
samples	O
,	O
along	O
with	O
no-template	O
controls	O
were	O
run	O
in	O
triplicate	O
with	O
each	O
of	O
20	O
primer	O
sets.All	O
experiments	O
were	O
independently	O
performed	O
in	O
duplicate	O
three	O
times	O
,	O
each	O
time	O
using	O
1μg	O
of	O
template	O
RNA	O
.	O

Violet	O
rectangles	O
,	O
δ-amastin	O
5′-	O
and	O
3′-flanking	O
regions	O
δ-ama	O
FRs	O
;	O
blue	O
rectangle	O
,	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
I-II	O
intergenic	O
region	O
GAPDH	O
IR	O
;	O
magenta	O
arrow	O
,	O
neo	O
;	O
green	O
arrow	O
,	O
enhanced	O
green	O
fluorescence	O
protein	O
EGFP	O
;	O
red	O
highlights	O
,	O
position	O
of	O
the	O
T.	O
brucei	O
dihydrolipoyl	O
dehydrogenase	O
mTP	O
mito	O
and	O
the	O
peroxisomal	O
targeting	O
sequence	O
type	O
1	O
PTS1.All	O
arrays	O
had	O
a	O
scale	O
factor	O
lower	O
than	O
1.4-fold	O
away	O
from	O
the	O
average	O
scale	O
factor	O
for	O
all	O
samples	O
,	O
a	O
GAPDH	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
3':5	O
'	O
ratio	O
at	O
around	O
1	O
and	O
a	O
β-actin	O
3':5	O
'	O
ratio	O
of	O
under	O
2.2	O
.	O

Although	O
gene	O
vaccines	O
have	O
shown	O
effectiveness	O
in	O
clinical	O
trials	O
6-13	O
,	O
only	O
a	O
few	O
trials	O
have	O
been	O
completed	O
in	O
oncology	O
patients	O
,	O
and	O
the	O
results	O
have	O
been	O
mixed	O
14-19.GAPDHp	O
,	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
promoter	O
.	O

b	O
,	O
c	O
Equivalent	O
amounts	O
of	O
the	O
resulting	O
protein	O
samples	O
from	O
undifferentiated	O
or	O
differentiating	O
3	O
days	O
adult	O
neural	O
progenitor	O
cells	O
were	O
analyzed	O
by	O
western	O
blot	O
for	O
the	O
presence	O
of	O
the	O
indicated	O
proteins.The	O
expression	O
data	O
of	O
human	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
GAPDH	O
,	O
Hs99999905	O
and	O
mouse	O
beta-actin	O
Mm00607939	O
were	O
used	O
as	O
an	O
endogenous	O
control	O
.	O

The	O
quantification	O
was	O
performed	O
with	O
a	O
LightCycler®	O
instrument	O
using	O
the	O
LightCycler	O
Fast	O
Start	O
DNA	O
Master	O
SYBR	O
green	O
I	O
kit	O
Roche	O
Diagnostics.Glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
GAPDH	O
is	O
a	O
loading	O
control	O
.	O

In	O
qRT-PCR	O
,	O
the	O
relative	O
levels	O
of	O
target	O
mRNA	O
were	O
normalized	O
to	O
those	O
of	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase.Epidermal	O
growth	O
factor	O
EGF	O
stimulates	O
increased	O
nuclear	O
localization	O
of	O
Jab1	O
in	O
MDA-MB-231	O
and	O
MDA-MB-468	O
breast	O
cancer	O
cell	O
lines	O
.	O

EGFR	O
,	O
epidermal	O
growth	O
factor	O
receptor	O
;	O
GAPDH	O
,	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
;	O
Jab1	O
,	O
c-Jun	O
activation	O
domain-binding	O
protein-1	O
;	O
pEGFR	O
,	O
phosphorylated	O
epidermal	O
growth	O
factor	O
receptor.Clearly	O
,	O
R5020	O
was	O
unable	O
to	O
regulate	O
prostate-specific	PROT
antigen	PROT
transcript	O
expression	O
,	O
but	O
both	O
DHT	O
and	O
MPA	O
were	O
able	O
to	O
do	O
so	O
.	O

The	O
upstream	O
and	O
downstream	O
primers	O
used	O
for	O
amplification	O
of	O
RARα1	O
and	O
RARα2	O
were	O
as	O
follows	O
:	O
RARα1	O
,	O
5'-GCCAGGCGCTCTGACCACTC-3	O
'	O
and	O
5'-AGCCCTTGCAGCCCTCACAG-3	O
'	O
;	O
RARα2	O
,	O
5'-ACTCCGCTTTGGAATGGCTCAAAC-3	O
'	O
and	O
5'-AGCCCTTGCAGCCCTCACAG-3'.Violet	O
rectangles	O
,	O
δ-amastin	O
5′-	O
and	O
3′-flanking	O
regions	O
δ-ama	O
FRs	O
;	O
blue	O
rectangle	O
,	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
I-II	O
intergenic	O
region	O
GAPDH	O
IR	O
;	O
magenta	O
arrow	O
,	O
neo	O
;	O
green	O
arrow	O
,	O
enhanced	O
green	O
fluorescence	O
protein	O
EGFP	O
;	O
red	O
highlights	O
,	O
position	O
of	O
the	O
T.	O
brucei	O
dihydrolipoyl	O
dehydrogenase	O
mTP	O
mito	O
and	O
the	O
peroxisomal	O
targeting	O
sequence	O
type	O
1	O
PTS1	O
.	O

Primers	O
used	O
were	O
:	O
rat	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
GAPDH	O
PPR06557A	O
Superarray	O
,	O
rat	O
CXCR4	O
5	O
'	O
AGGAACTGAACGCTCCAGAA	O
3	O
'	O
and	O
5	O
'	O
AACCACACAGCACAACCAAA	O
3	O
'	O
,	O
human	O
CXCR4	O
5	O
'	O
CTCCAAGCTGTCACACTCCA	O
3	O
'	O
and	O
5	O
'	O
TCGATGCTGATCCCAATGTA	O
3	O
'	O
,	O
human	O
and	O
rat	O
CXCR7	O
5	O
'	O
GCACTACATCCCGTTCACCT	O
3	O
'	O
and	O
5'AAGGCCTTCATCAGCTCGTA	O
3	O
'	O
.	O

Gene	O
expression	O
in	O
FM	O
adult	O
skin	O
and	O
muscle	O
tissue.Dickkopf-1	O
is	O
regulated	O
via	O
Cdc42	O
and	O
Rho	O
in	O
breast	O
cancer	O
.	O

For	O
instance	O
,	O
in	O
the	O
term	O
Prostate	O
Specific	O
Antigen	O
the	O
word	O
Prostate	O
appears	O
less	O
than	O
1	O
,000	O
times	O
in	O
the	O
dictionary.Cell	O
lysates	O
were	O
collected	O
as	O
described	O
previously	O
6	O
.	O

Clearly	O
,	O
R5020	O
was	O
unable	O
to	O
regulate	O
prostate-specific	PROT
antigen	PROT
transcript	O
expression	O
,	O
but	O
both	O
DHT	O
and	O
MPA	O
were	O
able	O
to	O
do	O
so.We	O
validated	O
the	O
interaction	O
between	O
NINLisoB	O
and	O
MICAL3	O
by	O
reciprocal	O
co-immunoprecipitations	O
Fig	O
6b	O
and	O
confirmed	O
that	O
endogenously	O
expressed	O
MICAL3	O
is	O
present	O
at	O
the	O
photoreceptor	O
connecting	O
cilium	O
in	O
rat	O
retina	O
P20	O
,	O
partially	O
overlapping	O
with	O
the	O
cilium	O
and	O
basal	O
body	O
marker	O
polyglutamylated	O
tubulin	O
Fig	O
7b–7d	O
’	O
.	O

The	O
alternative	O
scenario	O
of	O
a	O
class-2	O
myosin	O
in	O
the	O
LECA	O
is	O
not	O
in	O
agreement	O
with	O
the	O
phylogenetic	O
grouping	O
of	O
the	O
heterolobosean	O
homologs	O
and	O
would	O
require	O
at	O
least	O
three	O
independent	O
class-2	O
myosin	O
loss	O
events	O
,	O
two	O
loss	O
events	O
in	O
the	O
ancestors	O
of	O
the	O
kinetoplastids	O
and	O
parabasalids	O
and	O
one	O
in	O
the	O
ancestor	O
of	O
the	O
Diaphoretickes	O
SAR	O
+	O
Archaeplastida	O
if	O
the	O
Diaphoretickes	O
is	O
considered	O
a	O
monophyletic	O
taxon	O
Additional	O
file	O
1	O
:	O
Figure	O
S14.Across	O
breed	O
and	O
tissue	O
gene	O
expression	O
analysis	O
by	O
SYBR	O
Green	O
qPCR	O
of	O
*FM	O
Silkie	O
breed	O
tissue	O
and	O
*N	O
New	O
Hampshire	O
breed	O
calibrated	O
to	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
GAPDH	O
.	O

The	O
myosin	O
heavy	O
chain	O
locus	O
represents	O
a	O
well	O
characterized	O
example	O
of	O
transcriptional	O
regulation	O
of	O
both	O
protein-coding	O
25	O
and	O
noncoding	O
DCM-associated	O
genes	O
26.CHX	O
cycloheximide	O
,	O
GAPDH	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
,	O
TGF	O
transforming	O
growth	O
factor	O
Error	O
bars	O
indicate	O
SE.Direct	O
evidence	O
for	O
the	O
in	O
vivo	O
importance	O
of	O
FAK	O
in	O
tumourigenesis	O
derives	O
from	O
several	O
recent	O
studies	O
in	O
which	O
components	O
of	O
the	O
integrin	O
signaling	O
pathway	O
were	O
selectively	O
ablated	O
in	O
the	O
germline	O
of	O
mice	O
.	O

PCR	O
amplification	O
of	O
each	O
DNA	O
fragment	O
and	O
gene	O
was	O
performed	O
using	O
TaKaRa	O
EX	O
or	O
LA	O
Taq	O
Takara	O
,	O
Kyoto	O
,	O
Japan	O
,	O
according	O
to	O
the	O
manufacturer	O
's	O
protocol.Immunotherapy	O
for	O
cancer	O
using	O
gene	O
vaccines	O
is	O
in	O
its	O
infancy	O
,	O
and	O
the	O
development	O
of	O
new	O
approaches	O
and	O
techniques	O
is	O
anticipated	O
21-24	O
.	O

After	O
endogenous	O
peroxidase	O
blocking	O
3	O
%	O
wv	O
H2O2	O
,	O
sections	O
were	O
pre-incubated	O
in	O
blocking	O
solution	O
10	O
%	O
goat	O
serum	O
for	O
1	O
h	O
at	O
room	O
temperature	O
and	O
incubated	O
overnight	O
at	O
4	O
°C	O
at	O
1100	O
dilution	O
with	O
calponin	O
antibody	O
ab46794	O
,	O
Abcam	O
,	O
UK.Error	O
bars	O
represent	O
standard	O
error	O
of	O
the	O
mean	O
.	O

However	O
,	O
it	O
was	O
recently	O
demonstrated	O
that	O
a	O
gene	O
vaccine	O
for	O
prostate-specific	PROT
antigen	PROT
broke	O
immunologic	O
tolerance	O
and	O
induced	O
cellular	O
immunity	O
20.Relative	O
quantification	O
of	O
the	O
expression	O
of	O
each	O
gene	O
was	O
calculated	O
and	O
normalised	O
to	O
averaged	O
cyclophilin	O
and	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
GAPDH	O
expression	O
levels	O
as	O
indicated	O
using	O
the	O
2-ΔΔCt	O
method	O
21	O
.	O

,	O
18S	O
rRNA	O
,	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
GAPDH	O
,	O
and	O
TATA	O
binding	O
protein	O
TBP	O
,	O
was	O
measured	O
in	O
the	O
samples	O
by	O
real-time	O
RT-PCR	O
using	O
TaqMan	O
Gene	O
Expression	O
Assays	O
run	O
on	O
an	O
ABI	O
PRISM	O
7900HT	O
Fast	O
Real-Time	O
PCR	O
System	O
Applied	O
Biosystems	O
.	O

f	O
Quantitative	O
RT-PCR	O
analysis	O
of	O
IL-1β	O
expression	O
levels	O
normalised	O
to	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase.These	O
lists	O
contain	O
nine	O
genes	O
,	O
including	O
four	O
encoding	O
enzymes	O
of	O
the	O
glycolytic	O
pathway	O
Hexokinase	O
A	O
Hex-A	O
,	O
Phosphoglycerate	O
kinase	O
Pgk	O
,	O
Phosphoglucose	O
isomerase	O
Pgi	O
and	O
both	O
genes	O
encoding	O
Glyceraldehyde	O
3	O
phosphate	O
dehydrogenase	O
GAPDH1	O
and	O
GAPDH2	O
and	O
our	O
data	O
indicated	O
that	O
all	O
nine	O
are	O
regulated	O
by	O
Smaug	O
at	O
the	O
level	O
of	O
stability	O
andor	O
translation	O
repression	O
Additional	O
file	O
22	O
.	O

However	O
,	O
the	O
200	O
kD	O
recognition	O
protein	O
was	O
demonstrated	O
to	O
be	O
myosin	O
heavy	O
chain	O
derived	O
from	O
degraded	O
larval	O
muscle	O
,	O
but	O
not	O
from	O
pupal	O
hemocyte	O
14.However	O
,	O
it	O
was	O
recently	O
demonstrated	O
that	O
a	O
gene	O
vaccine	O
for	O
prostate-specific	PROT
antigen	PROT
broke	O
immunologic	O
tolerance	O
and	O
induced	O
cellular	O
immunity	O
20	O
.	O

Cells	O
were	O
treated	O
for	O
6	O
or	O
12	O
hours	O
with	O
ethanol	O
or	O
hormones.ADPG	O
,	O
ADP-Glucose	O
ADPG	O
;	O
BGAL	O
,	O
β-galactosidase	O
;	O
BGLU	O
,	O
β-1	O
,3-glucosidase	O
;	O
BXL	O
,	O
β-xylosidase	O
;	O
CER3WAX2	O
,	O
fatty	O
acid	O
hydroxylase	O
superfamily	O
;	O
CER4FAR3	O
,	O
fatty	O
acid	O
reductase	O
3	O
;	O
DAHP	O
,	O
3-deoxy-D-arabino-heptulosonate-7-phosphate	O
;	O
DHAP	O
,	O
dihydroxyacetone	O
phosphate	O
;	O
E4P	O
,	O
erythrose-4-phosphate	O
;	O
F6P	O
,	O
Fructose-6-Phosphate	O
;	O
GAE	O
,	O
UDP-D-glucuronate-4-epimerase	O
;	O
G1P	O
,	O
Glucose-1-Phosphate	O
;	O
G3P	O
,	O
Glyceraldehyde-3-phosphate	O
;	O
G6P	O
,	O
Glucose-6-Phosphate	O
;	O
KCR	O
,	O
beta-ketoacyl	O
reductase	O
;	O
KCS	O
,	O
3-ketoacyl-CoA	O
synthase	O
;	O
LTP	O
,	O
lipid	O
transfer	O
protein	O
;	O
PE	O
,	O
pectinesterase	O
;	O
PEP	O
,	O
phosphoenolpyruvate	O
;	O
PG2	O
,	O
polygalacturonase	O
2	O
;	O
PHS2	O
,	O
alpha-glucan	O
phosphorylase	O
2	O
;	O
PL	O
,	O
Pectate	O
lyase	O
;	O
R5P	O
,	O
Ribose-5-phosphate	O
;	O
SUS	O
,	O
sucrose	O
synthase	O
;	O
UGD	O
,	O
UDP-glucuronate	O
decarboxylase	O
;	O
UGDH	O
,	O
UDP-glucose-6-dehydrogenase	O
;	O
UGP	O
,	O
UDP-glucose	O
pyrophosphorylase	O
;	O
VLCFA	O
,	O
very	O
long	O
chain	O
fatty	O
acids	O
;	O
WBC1	O
,	O
ATP-binding	O
cassette	O
transporter	O
white-brown	O
complex	O
homolog	O
protein	O
1	O
;	O
XTH	O
,	O
Xyloglucan	O
endotransglycosylase	O
.	O

Similar	O
to	O
GFP-AD-Cterm	O
3xThr	O
,	O
AD-Cterm-GFP	O
3xThr	O
formed	O
clustered	O
or	O
larger	O
structures	O
when	O
protein	O
was	O
assembled	O
for	O
more	O
than	O
10	O
min	O
prior	O
to	O
imaging	O
,	O
whereas	O
BTFs	O
were	O
most	O
prevalent	O
when	O
protein	O
was	O
assembled	O
for	O
2–5	O
min.Oligonucleotide	O
primers	O
see	O
Additional	O
file	O
8	O
were	O
designed	O
to	O
amplify	O
each	O
N.	O
vectensis	O
NR	O
,	O
as	O
well	O
as	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
GAPDH	O
and	O
18S	O
ribosomal	O
RNA	O
18S	O
.	O

DAPI	O
,	O
4'-6-diamidino-2-phenylindole	O
;	O
EGFR	O
,	O
epidermal	O
growth	O
factor	O
receptor	O
;	O
GAPDH	O
,	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
;	O
Jab1	O
,	O
c-Jun	O
activation	O
domain-binding	O
protein-1	O
;	O
pEGFR	O
,	O
phosphorylated	O
epidermal	O
growth	O
factor	O
receptor.Being	O
a	O
carboxyglutamate	O
peptidase	O
,	O
it	O
cleaves	O
C-terminal	O
Glu	O
residues	O
.	O

Inhibition	O
of	O
geranylgeranylation	O
by	O
GGTI-298	O
,	O
atorvastatin	O
and	O
zoledronic	O
acid	O
,	O
farnesylation	O
by	O
FTI-277	O
,	O
atorvastatin	O
and	O
zoledronic	O
acid	O
as	O
well	O
as	O
their	O
selective	O
reversal	O
by	O
the	O
substrates	O
was	O
confirmed	O
by	O
assessing	O
unfarnesylated	O
RAS	O
and	O
ungeranylated	O
RAP1A	O
in	O
western	O
blot.In	O
the	O
nucleation	O
phase	O
,	O
a	O
parallel	O
dimer	O
forms	O
in	O
which	O
two	O
myosin	O
monomers	O
self-associate	O
in	O
a	O
parallel	O
orientation	O
with	O
a	O
14-nm	O
stagger	O
.	O

Gene	O
expression	O
analysis	O
by	O
SYBR	O
Green	O
qPCR	O
of	O
*FM	O
Silkie	O
breed	O
tissue	O
normalized	O
to	O
the	O
*N	O
New	O
Hampshire	O
breed	O
and	O
calibrated	O
to	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
GAPDH.The	O
plant	O
lectins	O
SBA	O
,	O
UEA-I	O
and	O
PNA	O
,	O
as	O
recombinant	O
and	O
native	O
frutalin	O
,	O
were	O
able	O
to	O
differentiate	O
cells	O
from	O
distinct	O
prostate	O
histological	O
tissues	O
.	O

Columns	O
,	O
mean	O
values	O
n	O
=	O
3	O
;	O
bars	O
,	O
SD.Relative	O
expression	O
level	O
of	O
the	O
gene	O
of	O
interest	O
was	O
calculated	O
with	O
the	O
comparative	O
2method	O
,	O
where	O
ΔCt	O
=	O
target	O
Ct	O
-	O
control	O
Ct	O
,	O
ΔΔCt	O
=ΔCt	O
target	O
-	O
ΔCt	O
calibrator.and	O
all	O
samples	O
were	O
normalized	O
to	O
the	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
GAPDH	O
gene	O
for	O
PCR	O
and	O
to	O
GAPDH	O
and	O
human	O
aminolevulinate	O
delta-synthase	O
1	O
ALAS1	O
QuantiTect	O
Primer	O
Assay	O
,	O
Qiagen	O
GmbH	O
,	O
Hilden	O
,	O
Germany	O
genes	O
for	O
qRT-PCR	O
.	O

Primers	O
5′-AGG	O
TTC	O
TGG	O
TGG	O
GAC	O
CCT	O
GTGT-3′	O
and	O
5′-AGA	O
AAG	O
CAG	O
TGT	O
CCC	O
CAA	O
CAGG-3′	O
were	O
used	O
to	O
amplify	O
the	O
full	O
length	O
Hhat	O
mRNA	O
in	O
wild-type	O
,	O
heterozygous	O
and	O
mutant	O
embryos.GAPDH	O
,	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
.	O

When	O
recombined	O
with	O
human	O
embryonic	O
stem	O
cells	O
,	O
the	O
UGM	O
directs	O
differentiation	O
into	O
mature	O
human	O
prostate	O
tissue	O
expressing	O
prostate-specific	PROT
antigen	PROT
45.The	O
following	O
antibodies	O
were	O
used	O
for	O
Western	O
blotting	O
:	O
rabbit	O
anti-MMP2	O
,	O
-3	O
,	O
-9	O
,	O
-12	O
,	O
-13	O
,	O
and	O
-14	O
Epitomics	O
;	O
rabbit	O
anti-ADAMTS4	O
Abcam	O
;	O
goat	O
anti-IL6	O
R	O
&	O
D	O
Systems	O
;	O
rabbit	O
anti-ADAMTS5	O
Thermo	O
Scientific	O
;	O
rabbit	O
anti-iNOS	O
,	O
rabbit	O
anti-VEGF	O
,	O
goat	O
anti-RANKL	O
,	O
and	O
goat	O
anti-TNFα	O
Santa	O
Cruz	O
;	O
and	O
mouse	O
anti-COX2	O
Cayman	O
Chemical	O
.	O

However	O
,	O
the	O
AR	O
were	O
not	O
functional	O
,	O
based	O
on	O
transcription	O
assays	O
with	O
MPA	O
or	O
DHT	O
,	O
and	O
by	O
RT-PCR	O
transcript	O
expression	O
of	O
the	O
androgen-responsive	O
prostate-specific	PROT
antigen	PROT
PSA	O
gene	O
not	O
shown.Triplicate	O
determinations	O
were	O
performed	O
in	O
a	O
96-well	O
optical	O
plate	O
for	O
each	O
target	O
,	O
using	O
5	O
µl	O
cDNA	O
,	O
1.25	O
µl	O
TaqMan	O
Gene	O
Expression	O
Assay	O
,	O
12.5	O
µl	O
TaqMan	O
Universal	O
PCR	O
Master	O
Mix	O
Applied	O
Biosystems	O
and	O
6.25	O
µl	O
water	O
in	O
each	O
25	O
µl	O
reaction	O
.	O

This	O
is	O
especially	O
true	O
for	O
tests	O
that	O
generate	O
a	O
large	O
amount	O
of	O
information	O
,	O
and	O
potentially	O
large	O
amounts	O
of	O
ambiguous	O
information	O
as	O
well	O
as	O
false	O
positives	O
and	O
incidental	O
findings.It	O
was	O
used	O
both	O
to	O
document	O
a	O
lack	O
of	O
sexually	O
dimorphic	O
expression	O
of	O
a	O
housekeeping	O
gene	O
and	O
as	O
a	O
basis	O
for	O
normalization	O
when	O
calculating	O
fold-differences	O
between	O
the	O
sexes	O
ΔΔCT	O
,	O
see	O
below	O
.	O

Relative	O
expression	O
level	O
of	O
the	O
gene	O
of	O
interest	O
was	O
calculated	O
with	O
the	O
comparative	O
2method	O
,	O
where	O
ΔCt	O
=	O
target	O
Ct	O
-	O
control	O
Ct	O
,	O
ΔΔCt	O
=ΔCt	O
target	O
-	O
ΔCt	O
calibrator.and	O
all	O
samples	O
were	O
normalized	O
to	O
the	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
GAPDH	O
gene	O
for	O
PCR	O
and	O
to	O
GAPDH	O
and	O
human	O
aminolevulinate	O
delta-synthase	O
1	O
ALAS1	O
QuantiTect	O
Primer	O
Assay	O
,	O
Qiagen	O
GmbH	O
,	O
Hilden	O
,	O
Germany	O
genes	O
for	O
qRT-PCR.The	O
antibody	O
to	O
S100A7	O
was	O
a	O
rabbit	O
polyclonal	O
generated	O
and	O
described	O
previously	O
6	O
,21	O
.	O

Data	O
were	O
normalized	O
using	O
the	O
ratio	O
of	O
the	O
target	O
cDNA	O
concentration	O
to	O
that	O
of	O
the	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
gapdh	O
gene.GAPDH	O
,	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
.	O

3	O
,	O
Table	O
1.Because	O
PMSA	O
prostate-specific	O
membrane	O
antigen	O
is	O
overexpressed	O
on	O
most	O
prostate	O
cancer	O
cells	O
,	O
it	O
is	O
an	O
attractive	O
target	O
for	O
therapeutic	O
delivery	O
.	O

Tendon	O
constructs	O
were	O
fixed	O
in	O
4	O
%	O
paraformaldehyde	O
for	O
48	O
h	O
,	O
longitudinally	O
embedded	O
in	O
paraffin	O
and	O
cut	O
into	O
4	O
μm	O
thick	O
sections	O
on	O
poly-L-lysine-coated	O
slide.The	O
following	O
primer	O
sequences	O
were	O
used	O
:	O
IL-1β	O
5'-GCAACTGTTCCTGAACTCAAC-3	O
'	O
and	O
5'-ATCTTTTGGGGTCCGTCAACT-3	O
'	O
,	O
Cox-2	O
5	O
'	O
TGAGCAACTATTCCAAACCAG-3	O
'	O
and	O
GCACGTAGTCTTCGATCACTATC	O
,	O
cyclophilin	O
5'-TGAGCACTGGGGAGAAAGG-3	O
'	O
and	O
5'TTGCCATCCAGCCACTCAG-3	O
'	O
,	O
GAPDH	O
5'-TGACCACAGTCCATGCCATC-3	O
'	O
and	O
5'-GACGGACACATTGGGGGTAG-3	O
'	O
.	O

Interestingly	O
,	O
glycerol	O
3-phosphate	O
dehydrogenase	O
gpsA	O
,	O
MHO_1690	O
was	O
present	O
in	O
both	O
M.	O
hominis	O
and	O
U.	O
parvum.In	O
experiments	O
performed	O
to	O
study	O
the	O
regulation	O
of	O
BCAR3	O
by	O
TGFβ	O
,	O
CTGF	O
was	O
used	O
as	O
a	O
positive	O
control	O
and	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
was	O
used	O
as	O
an	O
internal	O
control	O
.	O

DAPI	O
,	O
4'-6-diamidino-2-phenylindole	O
;	O
GAPDH	O
,	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
;	O
Jab1	O
,	O
c-Jun	O
activation	O
domain-binding	O
protein-1.Chromatin	O
immunoprecipitation	O
ChIP	O
was	O
performed	O
using	O
the	O
Pierce	O
Agarose	O
ChIP	O
Kit	O
Pierce	O
BiotechnologyThermo	O
Fisher	O
Scientific	O
,	O
Rockford	O
,	O
IL	O
,	O
USA	O
according	O
to	O
the	O
manufacturer	O
’	O
s	O
instructions	O
.	O

CHX	O
cycloheximide	O
,	O
GAPDH	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
,	O
TGF	O
transforming	O
growth	O
factorTop	O
proteins	O
enriched	O
in	O
the	O
old	O
TEC	O
included	O
cytoskeleton	O
organization	O
proteins	O
calponin	O
1	O
,	O
palladin	O
,	O
collagens	O
COL3A1	O
,	O
COL4A2	O
,	O
COL12A1	O
and	O
transforming	O
growth	O
factor	O
beta-induced	O
protein	O
TGFBI	O
Fig	O
.	O

e	O
Increased	O
Jab1	O
nuclear	O
expression	O
positively	O
correlated	O
to	O
EGF	O
dose.b	O
Cells	O
transfected	O
with	O
pAEX	O
cassettes	O
encoding	O
the	O
EGFP	O
,	O
mito-EGFP	O
containing	O
an	O
N-terminal	O
mTP	O
,	O
or	O
EGFP-SKL	O
containing	O
the	O
C-terminal	O
PTS1	O
were	O
spread	O
on	O
polylysine-coated	O
glass	O
slides	O
,	O
fixed	O
in	O
2	O
%	O
vv	O
ice-cold	O
solution	O
of	O
paraformaldehyde	O
in	O
PBS	O
,	O
and	O
stained	O
with	O
DAPI	O
for	O
5	O
min	O
before	O
visualization	O
.	O

Primers	O
to	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
Gapdh	O
5′-AGC	O
CTC	O
GTC	O
CCG	O
TAG	O
ACA	O
AAAT-3′	O
and	O
5′-ACC	O
AGG	O
AAA	O
TGA	O
GCT	O
TGA	O
CAAA-3′	O
were	O
used	O
as	O
an	O
internal	O
positive	O
control.Primers	O
used	O
were	O
:	O
rat	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
GAPDH	O
PPR06557A	O
Superarray	O
,	O
rat	O
CXCR4	O
5	O
'	O
AGGAACTGAACGCTCCAGAA	O
3	O
'	O
and	O
5	O
'	O
AACCACACAGCACAACCAAA	O
3	O
'	O
,	O
human	O
CXCR4	O
5	O
'	O
CTCCAAGCTGTCACACTCCA	O
3	O
'	O
and	O
5	O
'	O
TCGATGCTGATCCCAATGTA	O
3	O
'	O
,	O
human	O
and	O
rat	O
CXCR7	O
5	O
'	O
GCACTACATCCCGTTCACCT	O
3	O
'	O
and	O
5'AAGGCCTTCATCAGCTCGTA	O
3	O
'	O
.	O

The	O
antibodies	O
used	O
for	O
immunoblotting	O
and	O
immunoprecipitation	O
were	O
Jab1	O
1:3	O
,000	O
Sigma-Aldrich	O
,	O
Oakville	O
,	O
ON	O
,	O
Canada	O
;	O
p27	O
1:200	O
BD	O
Biosciences	O
,	O
Mississauga	O
,	O
ON	O
,	O
Canada	O
;	O
Lamin	O
AC	O
1:1	O
,000	O
,	O
pEGFR	O
phosphorylated	O
EGFR	O
1:1	O
,000	O
,	O
extracellular	O
signal-regulated	O
kinase	O
ERK	O
1:1	O
,000	O
,	O
phosphorylated	O
ERK	O
pERK	O
1:1	O
,000	O
,	O
AKT	O
1:2	O
,000	O
,	O
and	O
pAKT	O
1:1	O
,000	O
Cell	O
Signaling	O
Technology	O
,	O
Inc.	O
,	O
Danvers	O
,	O
MA	O
,	O
USA	O
;	O
EGFR	O
1:1	O
,000	O
VWR	O
International	O
,	O
Mississauga	O
,	O
ON	O
,	O
Canada	O
;	O
and	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
GAPDH	O
1:4	O
,000	O
;	O
Advanced	O
ImmunoChemical	O
Inc.	O
,	O
Long	O
Beach	O
,	O
CA	O
,	O
USA.The	O
additional	O
role	O
of	O
the	O
recovery	O
stroke	O
above	O
can	O
be	O
another	O
bias	O
for	O
forward	O
stepping	O
even	O
in	O
the	O
presence	O
of	O
the	O
load	O
.	O

aFGF	O
:	O
fibroblast	O
growth	O
factor	O
gene	O
;	O
FGFR	O
:	O
fibroblast	O
growth	O
factor	O
receptor	O
gene	O
;	O
GAPDH	O
:	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
gene	O
;	O
HMBS	O
:	O
hydroxymethylbilane	O
synthase	O
gene	O
;	O
HNRPM	O
:	O
heterogeneous	O
nuclear	O
ribonucleoprotein	O
M	O
gene	O
;	O
HPRT1	O
:	O
hypoxanthine	O
phosphoribosyltransferase	O
1	O
gene	O
;	O
SRPR	O
:	O
signal	O
recognition	O
particle	O
receptor	O
gene	O
;	O
TBP	O
:	O
TATA	O
box	O
binding	O
protein	O
gene	O
;	O
F	O
:	O
forward	O
primer	O
;	O
R	O
:	O
reverse	O
primer	O
;	O
bp	O
:	O
base	O
pair.To	O
test	O
ChU-B	O
expression	O
levels	O
in	O
P.	O
pastoris	O
,	O
four	O
different	O
constructs	O
were	O
built	O
,	O
including	O
native	O
and	O
evolved	O
α-factor	O
prepro-leaders	O
in	O
combination	O
with	O
two	O
expression	O
vectors	O
:	O
pPICZαA	O
under	O
the	O
control	O
of	O
the	O
methanol	O
inducible	O
alcohol	O
oxidase	O
promoter	O
PAOX1	O
and	O
pGAPZαA	O
under	O
the	O
control	O
of	O
the	O
constitutive	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
promoter	O
PGAP	O
Figure	O
2	O
.	O

All	O
EGF	O
treatments	O
were	O
at	O
50	O
ngmL	O
for	O
4	O
hours.Quantitative	O
RT-PCR	O
was	O
used	O
to	O
analyse	O
IL-1β	O
mRNA	O
expression	O
normalised	O
to	O
levels	O
of	O
cyclophilin	O
and	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
GAPDH	O
.	O

cDNA	O
from	O
500	O
ng	O
of	O
total	O
RNA	O
was	O
synthesized	O
using	O
TaqMan	O
RT	O
reagents	O
according	O
to	O
the	O
manufacturer	O
's	O
instructions.Primers	O
to	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
Gapdh	O
5′-AGC	O
CTC	O
GTC	O
CCG	O
TAG	O
ACA	O
AAAT-3′	O
and	O
5′-ACC	O
AGG	O
AAA	O
TGA	O
GCT	O
TGA	O
CAAA-3′	O
were	O
used	O
as	O
an	O
internal	O
positive	O
control	O
.	O

Average	O
background	O
and	O
the	O
number	O
of	O
genes	O
called	O
present	O
42	O
%	O
to	O
48	O
%	O
in	O
liver	O
and	O
50	O
%	O
to	O
55	O
%	O
in	O
duodenum	O
were	O
similar	O
across	O
all	O
chips.The	O
primer	O
sequences	O
were	O
as	O
follows	O
:	O
Gm13344	O
accession	O
number	O
AB701678	O
and	O
AB701679	O
:	O
5′-ACGAATGGGGTGTTCAGACG-3′	O
sense	O
and	O
5′-CGACTGCCAGACCCAGGAAG-3′	O
antisense	O
,	O
generating	O
two	O
alternative	O
splicing	O
products	O
,	O
446-bp	O
and	O
297-bp	O
fragments	O
;	O
Gm13336	O
accession	O
number	O
AB701680	O
:	O
5′-TGACGCTTTGTGAGTGATCC-3′	O
sense	O
and	O
5′-AACACTCCTGTGATGTGTAG-3′	O
antisense	O
,	O
generating	O
a	O
226-bp	O
fragment	O
;	O
mGm13336	O
:	O
5′-TGACGCTTTGTGAGTGATCC-3′	O
sense	O
and	O
5′-GAACAATACGATTTCTTTTTACCTG-3′	O
antisense	O
,	O
generating	O
a	O
488-bp	O
fragment	O
;	O
Ptf1a	O
:	O
5′-TGAGGGACCTACCCGAATTG-3′	O
sense	O
and	O
5′-ACAATATGCACAAAGACGCG-3′	O
antisense	O
,	O
generating	O
a	O
1	O
,105-bp	O
fragment	O
;	O
Actb	O
β-actin	O
;	O
control	O
:	O
5′-ATGTACGTAGCCATCCAGGC-3′	O
sense	O
and	O
5′-AAGAAGGAAGGCTGGAAAAG-3′	O
antisense	O
,	O
generating	O
a	O
407-bp	O
fragment	O
;	O
Gapdh	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
;	O
control	O
:	O
5′-GGAAAGCTGTGGCGTGATG-3′	O
sense	O
and	O
5′-CTGTTGCTGTAGCCGTATTC-3′	O
antisense	O
,	O
generating	O
a	O
392-bp	O
fragment	O
.	O

One-tenth	O
of	O
the	O
final	O
reaction	O
volume	O
was	O
used	O
in	O
quantitative	O
SYBR	O
Synergy	O
Brands	O
green	O
RT-PCR	O
reactions	O
as	O
described	O
previously	O
20	O
using	O
the	O
Bio-Rad	O
iQ5	O
system	O
Bio-Rad	O
,	O
Hercules	O
,	O
CA	O
,	O
USA.More	O
recently	O
,	O
it	O
has	O
been	O
shown	O
that	O
prostate-specific	O
ablation	O
of	O
FAK	O
in	O
an	O
SV40	O
T	O
antigen	O
mouse	O
model	O
resulted	O
in	O
the	O
inability	O
of	O
prostate	O
tumours	O
to	O
progress	O
to	O
the	O
aggressive	O
neuroendocrine	O
phenotype	O
13	O
.	O

Images	O
are	O
representative	O
of	O
results	O
from	O
the	O
analysis	O
of	O
three	O
mice	O
per	O
genotype	O
and	O
treatment	O
time.Threonine	O
1	O
,823	O
is	O
positioned	O
within	O
a	O
cluster	O
of	O
positively	O
charged	O
a.a.	O
that	O
forms	O
part	O
of	O
the	O
196	O
a.a.	O
repeat	O
Luck-Vielmetter	O
et	O
al	O
.	O

The	O
DNA	O
was	O
purified	O
using	O
spin	O
columns	O
,	O
and	O
2	O
μl	O
of	O
the	O
DNA	O
was	O
used	O
in	O
the	O
semi-PCR	O
for	O
amplification	O
of	O
the	O
CIP2A	O
promoter	O
region	O
-139-16	O
bp.Another	O
model	O
postulates	O
that	O
regulation	O
occurs	O
at	O
the	O
level	O
of	O
assembly	O
intermediates	O
.	O

Gapdh	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
serves	O
as	O
a	O
chromatin	O
unbound	O
marker	O
;	O
Pol	O
II	O
RNA	O
Polymerase	O
II	O
is	O
a	O
chromatin	O
bound	O
marker.Myosin	O
tails	O
have	O
a	O
striking	O
pattern	O
of	O
charged	O
a.a.	O
,	O
with	O
an	O
average	O
positive	O
charge	O
over	O
14	O
a.a.	O
followed	O
by	O
an	O
average	O
negative	O
charge	O
over	O
14	O
a.a.	O
to	O
form	O
a	O
28-a.a.	O
charge	O
repeat	O
throughout	O
the	O
tail	O
McLachlan	O
and	O
Karn	O
1983	O
;	O
McLachlan	O
1984	O
.	O

The	O
introduction	O
of	O
negative	O
charge	O
by	O
phosphorylation	O
of	O
threonine	O
1	O
,823	O
could	O
disrupt	O
critical	O
charge-charge	O
interactions	O
required	O
for	O
assembly.Even	O
more	O
loss	O
events	O
would	O
have	O
to	O
be	O
considered	O
if	O
other	O
similarly	O
likely	O
early	O
and	O
independent	O
branchings	O
of	O
the	O
SAR	O
and	O
Archaeplastida	O
were	O
assumed	O
3	O
,	O
12	O
,	O
14	O
.	O

In	O
all	O
cases	O
,	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
GAPDH	O
was	O
analyzed	O
in	O
parallel	O
as	O
a	O
control.Error	O
bars	O
indicate	O
95	O
%	O
confidence	O
intervals	O
and	O
significance	O
thresholds	O
are	O
indicated	O
.	O

PCR	O
amplification	O
was	O
achieved	O
with	O
the	O
TaqMan	O
Gene	O
Expression	O
Assays	O
Hs00293728	O
for	O
human	O
SLC10A4	O
and	O
Mm00557788	O
for	O
mouse	O
Slc10a4	O
Applied	O
Biosystems.To	O
confirm	O
the	O
absence	O
of	O
Hhat	O
mRNA	O
in	O
Hhat	O
mutants	O
,	O
RNA	O
was	O
isolated	O
from	O
wild-type	O
and	O
mutant	O
embryos	O
RNeasy	O
kit	O
,	O
Qiagen	O
,	O
Valencia	O
,	O
CA	O
and	O
cDNA	O
libraries	O
were	O
created	O
using	O
the	O
Superscript	O
first	O
strand	O
kit	O
Invitrogen	O
,	O
Carlsbad	O
,	O
CA	O
.	O

cDNA	O
was	O
synthesized	O
using	O
the	O
Iscript	O
advanced	O
cDNA	O
synthesis	O
kit	O
for	O
RT-qPCR	O
Bio-Rad.Naringenin	O
Nar	O
reduces	O
the	O
release	O
of	O
TGF-β1	O
.	O

We	O
have	O
achieved	O
the	O
best	O
results	O
with	O
n	O
=	O
1	O
,000.Gene	O
expression	O
analysis	O
by	O
SYBR	O
Green	O
qPCR	O
of	O
*FM	O
Silkie	O
breed	O
tissue	O
normalized	O
to	O
the	O
*N	O
New	O
Hampshire	O
breed	O
and	O
calibrated	O
to	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
GAPDH	O
.	O

B	O
Basal	O
expression	O
of	O
DKK-1	O
in	O
different	O
breast	O
cancer	O
cell	O
lines	O
assessed	O
by	O
polymerase	O
chain	O
reaction	O
PCR	O
,	O
enzyme-linked	O
immunosorbent	O
assay	O
ELISA	O
and	O
western	O
Blot.To	O
quench	O
endogenous	O
peroxidase	O
,	O
the	O
sections	O
were	O
treated	O
with	O
0.3	O
%	O
vv	O
hydrogen	O
peroxide	O
,	O
and	O
then	O
blocked	O
with	O
3	O
%	O
goat	O
serum	O
for	O
30	O
min	O
,	O
followed	O
by	O
incubation	O
with	O
rabbit	O
anti	O
smooth	O
muscle	O
α-actin	O
Abcam	O
;	O
1∶500	O
or	O
rabbit	O
anti-calponin	O
1	O
Millipore	O
;	O
1∶200	O
at	O
4°C	O
overnight	O
.	O

Although	O
wild-type	O
HeLa	O
cervical	O
cancer	O
cells	O
are	O
both	O
PR	O
and	O
AR	O
negative	O
,	O
T47D-Y	O
PR-negative	O
cells	O
did	O
express	O
low	O
levels	O
of	O
endogenous	O
AR	O
by	O
western	O
blot.DAPI	O
,	O
4'-6-diamidino-2-phenylindole	O
;	O
GAPDH	O
,	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
;	O
Jab1	O
,	O
c-Jun	O
activation	O
domain-binding	O
protein-1	O
.	O

A	O
14-a.a.	O
window	O
makes	O
the	O
28-a.a.	O
repeat	O
apparent	O
Figure	O
1B	O
,	O
and	O
a	O
28-a.a.	O
window	O
averages	O
out	O
the	O
28-a.a.	O
pattern	O
,	O
making	O
the	O
196	O
a.a.	O
pattern	O
more	O
apparent	O
Figure	O
1C.When	O
recombined	O
with	O
human	O
embryonic	O
stem	O
cells	O
,	O
the	O
UGM	O
directs	O
differentiation	O
into	O
mature	O
human	O
prostate	O
tissue	O
expressing	O
prostate-specific	PROT
antigen	PROT
45	O
.	O

GAPDH	O
,	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase.Additionally	O
,	O
lectins	O
histochemical	O
studies	O
were	O
performed	O
to	O
detect	O
changes	O
in	O
glycoconjugates	O
associated	O
with	O
pre-neoplasic	O
and	O
neoplasic	O
transformation	O
of	O
the	O
prostate	O
8	O
,17	O
.	O

To	O
test	O
ChU-B	O
expression	O
levels	O
in	O
P.	O
pastoris	O
,	O
four	O
different	O
constructs	O
were	O
built	O
,	O
including	O
native	O
and	O
evolved	O
α-factor	O
prepro-leaders	O
in	O
combination	O
with	O
two	O
expression	O
vectors	O
:	O
pPICZαA	O
under	O
the	O
control	O
of	O
the	O
methanol	O
inducible	O
alcohol	O
oxidase	O
promoter	O
PAOX1	O
and	O
pGAPZαA	O
under	O
the	O
control	O
of	O
the	O
constitutive	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
promoter	O
PGAP	O
Figure	O
2.When	O
two	O
myosin	O
monomers	O
are	O
offset	O
by	O
14	O
nm	O
,	O
both	O
the	O
28-a.a.	O
and	O
196-a.a.	O
charge	O
repeats	O
are	O
aligned	O
to	O
maximize	O
charge	O
complementation	O
between	O
the	O
two	O
tails	O
De	O
Lozanne	O
1988	O
.	O

In	O
addition	O
,	O
it	O
has	O
been	O
reported	O
that	O
myosin	O
Va	O
moves	O
forward	O
under	O
∼2	O
pN	O
of	O
backward	O
load	O
5	O
,10	O
which	O
would	O
bring	O
the	O
junction	O
back	O
beyond	O
the	O
neutral	O
position	O
13	O
or	O
reverse	O
the	O
power	O
stroke	O
14	O
,	O
and	O
cancels	O
the	O
bias	O
introduced	O
by	O
the	O
attached	O
head	O
power	O
stroke.For	O
each	O
gene	O
,	O
the	O
forward	O
and	O
reverse	O
primer	O
sequences	O
,	O
the	O
length	O
of	O
the	O
resulting	O
PCR	O
product	O
using	O
cDNA	O
as	O
template	O
and	O
the	O
distance	O
from	O
the	O
polyA	O
tail	O
are	O
shown	O
,	O
as	O
is	O
the	O
information	O
about	O
whether	O
the	O
PCR	O
product	O
includes	O
an	O
exon-exon	O
boundary	O
.	O

Antigen	O
retrieval	O
was	O
performed	O
by	O
boiling	O
the	O
sections	O
in	O
10	O
mM	O
citrate	O
buffer	O
pH	O
6.0	O
for	O
20	O
min.Representative	O
Western	O
Blot	O
of	O
YAP	O
,	O
pYAP	O
,	O
Notch	O
intracellular	O
domain	O
NICD	O
,	O
Kaiso	O
,	O
β-catenin	O
β-catn	O
,	O
P120-catenin	O
P120-catn	O
,	O
actin	O
and	O
Glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
GAPDH	O
at	O
E17.5	O
E	O
and	O
P1	O
F.	O
Quantification	O
of	O
the	O
number	O
of	O
phospho-ribosomal	O
protein	O
positive	O
cells	O
D	O
showed	O
no	O
difference	O
between	O
control	O
and	O
Crb1Crb2	O
cKO	O
retinas	O
at	O
E17.5	O
and	O
P1.mRNA	O
expression	O
of	O
FN	O
and	O
endogenous	O
control	O
genes	O
,	O
i.e	O
.	O

Nevertheless	O
,	O
negative	O
binding	O
in	O
some	O
malignant	O
cases	O
was	O
also	O
reported	O
for	O
these	O
lectins	O
,	O
namely	O
for	O
the	O
T-antigen	O
specific	O
PNA	O
lectin	O
16	O
%	O
of	O
total	O
cases	O
31.Gapdh	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
serves	O
as	O
a	O
chromatin	O
unbound	O
marker	O
;	O
Pol	O
II	O
RNA	O
Polymerase	O
II	O
is	O
a	O
chromatin	O
bound	O
marker	O
.	O

The	O
activities	O
of	O
six	O
glycosidases	O
originating	O
form	O
LGTs	O
,	O
out	O
of	O
a	O
total	O
of	O
nine	O
required	O
to	O
degrade	O
N-glycansgangliosides	O
,	O
are	O
indicated	O
by	O
violet	O
arrows	O
,	O
with	O
their	O
respective	O
EC	O
numbers	O
in	O
pink	O
boxes.Furthermore	O
,	O
plots	O
of	O
mean	O
intensity	O
per	O
probe	O
position	O
averaged	O
over	O
all	O
probe	O
sets	O
had	O
very	O
similar	O
slopes	O
for	O
the	O
different	O
arrays	O
,	O
permitting	O
valid	O
comparisons	O
within	O
genes	O
across	O
arrays	O
.	O

PSA	O
-	O
prostate-specific	PROT
antigen	PROT
,	O
have	O
demonstrated	O
their	O
applicability	O
as	O
biomarkers	O
of	O
specific	O
secretory	O
functions	O
,	O
structural	O
components	O
and	O
developmental	O
alterations	O
of	O
this	O
gland	O
13-16.Thus	O
,	O
the	O
presence	O
of	O
multiple	O
cis-exonic	O
and	O
intronic	O
sequences	O
regulating	O
positively	O
or	O
negatively	O
alternative	O
splicing	O
can	O
be	O
correlated	O
with	O
the	O
complex	O
RT-PCR	O
expression	O
profile	O
of	O
FAK	O
isoforms	O
containing	O
various	O
combinations	O
of	O
exons	O
13	O
,	O
14	O
and	O
16	O
that	O
we	O
observed	O
in	O
adult	O
tissues	O
and	O
during	O
development	O
.	O

Glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
GAPDH	O
;	O
Ambion	O
,	O
Austin	O
,	O
TX	O
or	O
actin	O
Sigma	O
,	O
St	O
Louis	O
,	O
MO	O
,	O
USA	O
was	O
used	O
as	O
loading	O
control.To	O
measure	O
the	O
expression	O
of	O
ACTB	O
and	O
GAPDH	O
,	O
the	O
assays	O
Hs99999903_m1	O
and	O
Hs99999905_m1	O
,	O
obtained	O
from	O
Applied	O
Biosystems	O
Life	O
Technologies	O
,	O
Carlsbad	O
,	O
CA	O
,	O
were	O
used	O
and	O
run	O
on	O
a	O
CFX96	O
Real-Time	O
System	O
Bio-Rad	O
.	O

This	O
statistical	O
approach	O
is	O
similar	O
to	O
that	O
previously	O
described	O
by	O
Tarrant	O
and	O
colleagues	O
83.A	O
second	O
charge	O
repeat	O
found	O
only	O
in	O
the	O
C-terminal	O
68	O
kDa	O
of	O
the	O
Dictyostelium	O
myosin	O
tail	O
occurs	O
every	O
196	O
a.a.	O
Warrick	O
et	O
al	O
.	O

Oligonucleotide	O
primers	O
see	O
Additional	O
file	O
8	O
were	O
designed	O
to	O
amplify	O
each	O
N.	O
vectensis	O
NR	O
,	O
as	O
well	O
as	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
GAPDH	O
and	O
18S	O
ribosomal	O
RNA	O
18S.GAPDH	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
,	O
PKC	O
protein	O
kinase	O
C	O
,	O
TGF	O
transforming	O
growth	O
factor	O
,	O
PMA	O
phorbol	O
12-myristate	O
13-acetate	O
Error	O
bars	O
indicate	O
SE.Two	O
additional	O
enzymes	O
EC	O
numbers	O
in	O
orange	O
boxes	O
,	O
N-acetylneuraminate	O
lyase	O
and	O
acylglucosamine	O
2-epimerase	O
,	O
which	O
also	O
correspond	O
to	O
LGTs	O
,	O
could	O
contribute	O
to	O
the	O
further	O
metabolism	O
of	O
the	O
sugars	O
liberated	O
during	O
glycan	O
degradation	O
.	O

The	O
GAPDH	O
transcript	O
is	O
expressed	O
and	O
translated	O
at	O
similar	O
levels	O
in	O
yeast	O
and	O
hyphae	O
and	O
was	O
used	O
as	O
a	O
positive	O
control	O
for	O
GFP	O
expression	O
in	O
37°C	O
and	O
RT	O
grown	O
cells.When	O
AD-Cterm	O
3xThr	O
is	O
assembled	O
in	O
buffer	O
containing	O
50	O
mM	O
NaCl	O
with	O
10	O
mM	O
MgCl2	O
and	O
imaged	O
using	O
negative-stain	O
EM	O
,	O
it	O
forms	O
paracrystals	O
with	O
a	O
14-nm	O
98-a.a.	O
periodicity	O
,	O
corresponding	O
to	O
the	O
periodicity	O
of	O
charge	O
in	O
the	O
AD-through-C-terminal	O
region	O
of	O
the	O
myosin	O
tail	O
De	O
Lozanne	O
et	O
al	O
.	O

c	O
immunoblot	O
analysis	O
of	O
endogenous	O
HSPC111	O
expression	O
in	O
whole	O
cell	O
lysates	O
at	O
time	O
points	O
up	O
to	O
24	O
hours.PCR	O
products	O
were	O
run	O
in	O
a	O
1.5	O
%	O
agarose	O
gel	O
containing	O
ethidinium	O
bromide	O
.	O

Furthermore	O
,	O
the	O
UGCAUG	O
sequence	O
and	O
various	O
Fox	O
isoforms	O
have	O
been	O
shown	O
to	O
activate	O
the	O
splicing	O
of	O
neuron-specific	O
alternative	O
exons	O
63	O
,71	O
such	O
as	O
the	O
N30	O
exon	O
of	O
the	O
non-muscle	O
myosin	O
heavy	O
chain	O
II-B	O
74	O
or	O
the	O
N1	O
exon	O
of	O
Src	O
73.qRT-PCR	O
was	O
performed	O
by	O
diluting	O
RT	O
product	O
in	O
2×	O
Universal	O
PCR	O
MasterMix	O
and	O
20×	O
TaqMan	O
Gene	O
Expression	O
Assay	O
for	O
each	O
gene	O
to	O
be	O
measured	O
:	O
chromobox	O
homolog	O
7	O
CBX7	O
Hs00980916_g1	O
,	O
docking	O
protein	O
4	O
DOK4	O
Hs00902919_g1	O
,	O
early	O
growth	O
response	O
1	O
EGR1	O
Hs00152928_m1	O
,	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
GAPDH	O
4333764F	O
,	O
mediator	O
of	O
ErbB2-driven	O
cell	O
motility	O
MEMO1	O
Hs00831646_uH	O
,	O
N-myristoyltransferase	O
2	O
NMT2	O
Hs01013924_g1	O
and	O
nuclear	O
receptor-interacting	O
protein	O
1	O
NRIP1RIP140	O
Hs00942766_s1	O
.	O

